• SE Asia (HQ)

    +65 3158 9910

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

Resources

Australia

Approved Product Information
Consumer Medicine Information

Brunei

Approved ---

Malaysia

Approved Product Information
Consumer Medicine Information

New Zealand

Approved Data Sheet
Consumer Medicine Information

Philippines

Application Under Evaluation ---

Singapore

Approved Product Information

Thailand

Application to be Submitted ---

Vietnam

Application to be Submitted ---

General

  Healthcare Professional Information

Resources

Australia

Approved Product Information
Consumer Medicine Information

Malaysia

Application to be Submitted ---

Singapore

Application to be Submitted ---

New Zealand

Application Under Evaluation ---

General

  Access Program

Resources

Australia

Approved Product Information
Consumer Medicine Information

Brunei

Approved ---

Malaysia

Approved Product Information

Singapore

Approved Product Information

New Zealand

Application Submitted ---

Thailand

Application to be Submitted ---

Vietnam

Application to be Submitted ---

General

  Healthcare Professional Information
Access Program

Resources

Australia

Approved Product Information
Consumer Medicine Information

Singapore

Application Under Evaluation ---

General

  Access Program

Resources

Australia

Approved Product Information
Consumer Medicine Information

New Zealand

Application Under Evaluation ---
The Oncotype DX® Breast Cancer Assay provides patients and their physicians with individualised information about their breast cancer to guide decisions on how to proceed with treatment. More info
The Oncotype DX® Prostate Cancer Assay provides men with newly diagnosed, low-risk prostate cancer and their urologists, critical information to help guide decisions about treatment. More info

Meeting the unmet needs
of patients in Australia,
New Zealand and
Southeast Asia